Strados™ Respiratory Care Platform
Enabling clinicians to monitor respiratory health from hospital to home.
- FDA 510(k) cleared and CE marked
- Patient and clinician friendly
- Clinically validated
Technology Overview
Cardiopulmonary diseases such as COPD, asthma and heart failure are among the most difficult to manage, with more than five million patients discharged from the hospital each year and readmissions for COPD often exceeding 20% within 30 days. The Strados Respiratory Care Platform, which includes our FDA-cleared RESP Biosensor, allows clinicians to continuously monitor lung sounds including cough and wheeze to gain greater insight into respiratory status and make earlier interventions that can save lives and resources.
Albert Rizzo, MD | Chief Medical Officer at American Lung Society
Data Collection Capabilities
Monitor early indicators of worsening respiratory diseases such as COPD & Asthma
Cough
Allows for identification of cough frequency, severity, and type
Wheeze, Rhonchi & Crackles
Allows for identification of frequency and inspiratory/expiratory events
Respiratory Dynamics*
Measures shortness of breath via respiratory rate as well as activity level
*Not cleared by FDA and for investigational use only.
How our wearable device works
The Strados Respiratory Care Platform is clinician and patient-friendly
Configure
Device is attached to patient’s chest with adhesive either by clinician or patient
Connect
Lung sound data is transferred via bluetooth to patient mobile app after recording is started
Care
Mobile device transfers data to the cloud and clinician portal, allowing clinical teams to review data and diagnose
Why this… why now?
- Studies show patients don’t comply regularly with eDiaries
- Most patients report have difficulty with self-reporting of symptoms and identifying onset of acute events
- Auscultation with a stethoscope is limited to in-person visits, prone to interobserver variability and not archivable
- Standard of care such as spirometry and pulse oximetry suffer from user error and lagging indication of decompensation
- Increases in cough and wheeze as well as shortness of breath are early warning signs of a COPD or asthma flareup
Patient-Centered Design
The RESP Biosensor is small, unobtrusive and hands-free—patients even forget they’re wearing it. ‘Set it and forget it’, our wearable device records lung sounds continuously whether patients are sleeping, working out or enjoying time with family. That translates into more patient compliance and more complete data for clinicians and care teams.
Strados™ Clinician Portal
Supported by machine learning* with archivable patient data
Our machine learning algorithms* including CoughCheck™ and WheezeCheck™ identify and track events with high clinical accuracy.
*Machine learning algorithms not cleared by FDA
Lung recordings are depicted visually as spectrograms. Recordings are also available for playback.
Technologies such as machine learning have the potential to break the cycle of COPD-related readmissions and provide respiratory patients a better quality of life.
After the pandemic especially, we know that many patients are not always able to come into the hospital. Having the ability to see and monitor patients remotely is key.
Let’s Talk.
We’d love to know how we can help you and your patients.